Vaginal Dryness, Pain and Low Libido — During Cancer Treatment

This is an active area of discussion in oncology, not a settled question. Current ASCO and ESMO guidance acknowledges that systemic absorption from low-dose vaginal oestrogen is minimal, and for many patients the benefit may outweigh the theoretical risk — but the decision depends on your specific cancer type, stage, and how well non-hormonal options have worked for you. Do not use vaginal oestrogen without discussing it with your oncologist first. There is no single right answer that applies to every patient with a hormone-sensitive cancer.

Sometimes, but not always on its own. For patients who experience a temporary oestrogen drop from certain chemotherapy regimens, function may improve once hormone levels recover. For patients on long-term aromatase inhibitors or who have undergone surgical menopause, the change is more sustained and ongoing management is likely to help more than waiting. Either way, symptoms affecting your daily life or relationship during treatment are worth managing now. Waiting is a reasonable choice only if the symptoms are mild and not distressing you.

Egg freezing before chemotherapy starts gives the best outcomes, which is why the two-week window matters so much. Once chemotherapy has begun, the ovaries may be affected. That said, the situation depends on the specific drugs being used and how many cycles you have had. If you are between cycles or on a regimen with lower ovarian toxicity, a reproductive specialist can assess what remains possible. Do not assume the window has closed without asking a specialist who has seen your actual treatment plan.

ASCO guidance recommends stopping tamoxifen for at least three months before attempting conception. This washout period allows the drug to clear from your system, because tamoxifen can affect a developing pregnancy. Equally important: stopping tamoxifen early carries its own risk to your cancer treatment. This is a decision to make with your oncologist — not independently — weighing how much of your planned tamoxifen course you have completed against the reproductive timeline that matters to you.

Yes — and it is physical in origin, not a psychological failing. Oestrogen influences sexual desire as well as vaginal comfort. Fatigue, pain, anxiety, altered body image and the weight of a diagnosis all compound the hormonal effect. Naming it to your team means it can be addressed: treating the underlying dryness and pain, pelvic floor therapy, psychological support, and sometimes couples counselling can all make a real difference. You do not have to accept it as a fixed condition of being in treatment.

They serve different purposes and work best used together. A vaginal moisturiser is applied regularly — several times a week — to maintain hydration in the vaginal lining over time. A lubricant is used at the moment of intercourse to reduce friction and pain. Both are safe for most patients, including those with hormone-sensitive cancers. Choose water-based products rather than oil-based ones if you use latex contraception, and avoid products with fragrances or glycerine, which can irritate already-sensitive tissue.